What You Should Know:
– PrognomiQ, a healthcare company pioneering multi-omics approaches to disease detection, has secured $34M in Series D funding led by Seer, Inc., with participation from a new strategic investor and existing…
Continue Reading
Background: As the most malignant type of cancer in the female reproductive system, ovarian cancer (OC) has become the second leading cause of death among Chinese women. Chemotherapy is the main treatment for OC…
Continue Reading
What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract…
Continue Reading
The NHS is piloting an iPhone device and app that helps detect throat cancer earlier and give patients the all-clear for the disease faster.
An initial trial on triaged low-risk patients at University Hospitals of…
What You Should Know:
– Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus, a fund established in collaboration with the renowned MD…
Continue Reading
MicroQuin, a biotechnology startup, used the International Space Station (ISS) National Laboratory to grow 3D breast and prostate cancer cell cultures to learn more about how these cancers develop and grow. Via MicroQuin’s ISS National…
Continue Reading
What You Should Know:
– Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
– This investment, co-led by Smart Family…
Continue Reading
Introduction
Artificial intelligence (AI) is transforming breast cancer detection by enhancing early diagnosis and alleviating radiologist workload, essential for improving patient outcomes and screening efficiency. A recent study, conducted by researchers from Norway and Denmark,…
We developed and evaluated the Digital Platform for Exercise (DPEx): a decentralized, patient-centric approach designed to enhance all aspects of clinical investigation of exercise therapy. DPEx integrated provision of a treadmill with telemedicine and…
Continue Reading
Pictured L-R: Prof Sebastien Ourselin Director of AI4VBH, Lawrence Tallon, Deputy CEO of Guy’s and St. Thomas’ NHS Foundation Trust, and Franz Pfister, cofounder and CEO of deepc (Image provided by deepc)
Six NHS…
Continue Reading
